Atorvastatin-Medicated Dentifrice Significantly Inhibits CD4+ T Cell Proliferation: In vitro Pilot Study
Reports indicate that statins (cholesterol-lowering drugs), in addition to lowering cholesterol, have an immunomodulatory effect. This effect may be beneficial for the treatment of several diseases, including periodontal disease. The aim of the present study was to evaluate the immunomodulatory effe...
Guardado en:
Autores principales: | Rosenberg,David R, Kernitsky,Jeremy R, Andrade,Catherine X, Ramirez,Valeria, Violant,Deborah, Nart,José |
---|---|
Lenguaje: | English |
Publicado: |
Sociedad Chilena de Anatomía
2017
|
Materias: | |
Acceso en línea: | http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0717-95022017000200002 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
A VALIDATED DENSITOMETRIC METHOD FOR ANALYSIS OF TELMISARTAN AND ATORVASTATIN CALCIUM IN FIXED DOSE COMBINATION
por: PATIL,U. P, et al.
Publicado: (2010) -
Evaluation of Some Biological Aspects of the Presence of Abrasive Silica and Thickening Silica in Basic Formulations of Dentifrices
por: Pedrazzi,Vinícius, et al.
Publicado: (2009) -
Influence of Prolonged use of Desensitizing Dentifrices on Dentin Bond Strength of Self-Etching Adhesive System
por: Aguiar,Juliana Dias, et al.
Publicado: (2016) -
Chitosan-Coated PLGA Nanoparticles for Enhanced Ocular Anti-Inflammatory Efficacy of Atorvastatin Calcium
por: Arafa MG, et al.
Publicado: (2020) -
Effects of desensitizing dentifrices on dentin tubule occlusion and resistance to erosive challenges
por: Xiaoyi Zhao, et al.
Publicado: (2021)